13F Holdings
中文EN

BDTB Bodhi Tree Biotechnology Inc

Services-Management Consulting Services · OTC · SEC CIK 2041531 · Fiscal year ends 09/30

Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY48.0%
TTM net income YoY44.9%
TTM EPS YoY-20.8%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-310.2%
Net margin-313.6%
FCF margin—
EBITDA margin—

Returns

ROE-161.5%
ROA-156.6%
ROIC (approx.)-899.0%
Asset turnover0.50x

Leverage & solvency

Liabilities / assets24.6%
Debt / equity0.00x
Current ratio—
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.00x
Accruals ratio-0.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-09-30
Income statement
Revenue$17,000
SG&A expense$164,618
Operating income-$147,618
Pretax income-$147,616
Income tax$2,050
Net income-$149,666
EPS (basic)-0.01
EPS (diluted)-0.01
Weighted avg. shares (diluted)25.44M
Banking
Net interest income$2
Balance sheet
Cash & equivalents$109,404
Total assets$119,161
Total liabilities$0
Shareholders' equity$119,161
Shares outstanding25.44M
Cash flow statement
Operating cash flow-$150,166

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.